Clinical Trial

Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease

Study acronym: COPD-HIIT
Recruiting
View on ClinicalTrials.gov →
Summary
Beyond pulmonary complications, COPD presents with extrapulmonary manifestations including reduced cognitive, cardiovascular, and muscle function. While exercise training is the cornerstone in the non-pharmacological treatment of COPD, there is a need for new exercise training methods. The COPD-HIIT trial intend to investigate the effects and mechanisms of 12 weeks supramaximal high-intensity interval-training (HIIT) compared to moderate intensive continous training (MICT) in people with COPD and matched healthy controls on important clinical outcomes. The trial also intends to compare the effects of 24 months of exercise training (supramaximal HIIT or MICT) to usual care in people with COPD on brain health, cardiorespiratory fitness and muscle power; in people with COPD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-28; most recent amendment 2024-05-21.
Status change: Not Yet Recruiting → Recruiting 2023-10-09
Trial Details
NCT Number NCT06068322
Lead Sponsor Umeå University
Collaborators: Hasselt University, Swedish Heart Lung Foundation, European Research Council, The Swedish Research Council, Ziekenhuis Oost-Limburg, Strategic Research Area - Health Care Science
Conditions COPD, Healthy Controls
Enrollment 208 participants
Start Date 2023-11-09
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-23